1. Home
  2. THRX

THRX

Theseus Pharmaceuticals Inc.

Logo Theseus Pharmaceuticals Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

0

Theseus Pharmaceuticals Inc is a biopharmaceutical company focused on improving the lives of cancer patients through the discovery, development and commercialization of transformative targeted therapies. The company's development programs are designed to address drug resistance mutations in key driver oncogenes, which are mutated genes that cause cancer.

Founded: 2017 Country:
United States
United States
Employees: N/A City: CAMBRIDGE
Market Cap: 181.3M IPO Year: 2021
Target Price: $11.75 AVG Volume (30 days): 476.1K
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.34 EPS Growth: N/A
52 Week Low/High: $2.05 - $12.37 Next Earning Date: 03-07-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: